General Information of Drug (ID: DMV9FLB)

Drug Name
CNSA-001
Indication
Disease Entry ICD 11 Status REF
Gastroparesis DA41.00 Phase 2 [1]
Hyperphenylalaninemia 5C50 Phase 1/2 [2]
Drug Type
Small molecular drug
Cross-matching ID
PubChem CID
135398579
TTD ID
D3M7FK
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT03712124) A Study of CNSA-001 in Women With Diabetic Gastroparesis. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT03519711) A Study of CNSA-001 in Primary Tetrahydrobiopterin (BH4) Deficient Participants With Hyperphenylalaninemia. U.S. National Institutes of Health.